Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

ISR

IsoRay (ISR)

IsoRay Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:ISR
DateHeureSourceTitreSymboleSociété
24/04/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ISRIsoRay Inc
19/04/202422h05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:ISRIsoRay Inc
18/04/202422h11Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:ISRIsoRay Inc
18/04/202422h09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:ISRIsoRay Inc
16/04/202422h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:ISRIsoRay Inc
10/04/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:ISRIsoRay Inc
09/04/202422h25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:ISRIsoRay Inc
08/04/202422h12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:ISRIsoRay Inc
01/04/202413h46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:ISRIsoRay Inc
29/03/202412h35Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:ISRIsoRay Inc
28/03/202413h34Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:ISRIsoRay Inc
18/03/202421h18Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:ISRIsoRay Inc
08/03/202417h22Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:ISRIsoRay Inc
06/02/202401h18Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:ISRIsoRay Inc
01/02/202413h56Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:ISRIsoRay Inc
01/02/202413h38Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipAMEX:ISRIsoRay Inc
18/01/202422h49Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:ISRIsoRay Inc
17/01/202419h40Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]AMEX:ISRIsoRay Inc
14/11/202322h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ISRIsoRay Inc
14/06/202322h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ISRIsoRay Inc
14/06/202322h42Edgar (US Regulatory)Specialized Disclosure Report (sd)AMEX:ISRIsoRay Inc
15/05/202323h23Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ISRIsoRay Inc
15/05/202323h16Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ISRIsoRay Inc
01/05/202323h04Edgar (US Regulatory)Annual Transition Report (10-kt)AMEX:ISRIsoRay Inc
17/03/202322h09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ISRIsoRay Inc
08/03/202313h30GlobeNewswire Inc.Perspective Therapeutics Announces the Awarding of a $1 million Collaborative Grant to King’s College London to Support Radiobiology Research of Alpha Particle Therapy for CancerAMEX:ISRIsoRay Inc
22/02/202323h02GlobeNewswire Inc.Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific SessionAMEX:ISRIsoRay Inc
21/02/202312h02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:ISRIsoRay Inc
16/02/202322h05GlobeNewswire Inc.Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022AMEX:ISRIsoRay Inc
07/02/202323h48GlobeNewswire Inc.Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.AMEX:ISRIsoRay Inc
 Showing the most relevant articles for your search:AMEX:ISR